Sheel Biotech (NSE:SHEEL) ROCE %: 14.61% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SHEEL Sheel Biotech Ltd NSE:SHEEL
18 GF Score
Price ₹68.00
! 2 Warning Signs
View Full Analysis

What is Sheel Biotech ROCE %?

Sheel Biotech NSE:SHEEL 18 ROCE % is 14.61% as of Mar. 2026. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sheel Biotech's annualized ROCE % for the quarter that ended in Mar. 2026 was 14.61%.

Sheel Biotech  (NSE:SHEEL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sheel Biotech ROCE % Related Terms

Sheel Biotech ROCE % Historical Data

* Premium members only.

The historical data trend for Sheel Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sheel Biotech ROCE % Chart

Sheel Biotech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
7.49 10.22 17.30 16.91 14.61

Sheel Biotech Semi-Annual Data
Mar22 Mar23 Mar24 Mar25 Mar26
ROCE % 7.49 10.22 17.30 16.91 14.61
NSE:SHEEL
18GF Score
Sheel Biotech Ltd NSE:SHEEL
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sheel Biotech ROCE % Calculation

Sheel Biotech's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=159.304/( ( (1132.826 - 240.162) + (1457.843 - 169.728) )/ 2 )
=159.304/( (892.664+1288.115)/ 2 )
=159.304/1090.3895
=14.61 %

Sheel Biotech's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=159.304/( ( (1132.826 - 240.162) + (1457.843 - 169.728) )/ 2 )
=159.304/( ( 892.664 + 1288.115 )/ 2 )
=159.304/1090.3895
=14.61 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 14.61% mean?
Sheel Biotech (NSE:SHEEL) has a ROCE % of 14.61% as of Mar. 2026.
Is Sheel Biotech's ROCE % too high?
Sheel Biotech's current ROCE % is 14.61%. The Consumer Packaged Goods industry median ROCE % is 8.88. Sheel Biotech's value of 14.61% is 64.5% above this industry median. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's ROCE % compare to ADM and BG?
Sheel Biotech's ROCE % of 14.61% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROCE % is 8.88. Sheel Biotech's value of 14.61% is 64.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Consumer Packaged Goods company?
The median ROCE % among Consumer Packaged Goods companies is 8.88, based on 1,942 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sheel Biotech's current ROCE % of 14.61% is 64.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median ROCE % is 8.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current ROCE % is 14.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current ROCE % of 14.61%. The current ROCE % is 14.61% and 64.5% above the Consumer Packaged Goods industry median of 8.88. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current ROCE % is 14.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sheel Biotech Business Description

Address Guru Ravidas Marg, 8 Balaji Estates, 2nd Floor, Block-C, Kalkaji, South Delhi, New Delhi, IND, 110019
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score

Get the complete analysis for NSE:SHEEL

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹68.00
Price